Niosome-loaded silibinin and methotrexate for synergistic breast cancer combination chemotherapy: in silico and in vitro study.

Salemi A, Zenjanab MK, Adili Aghdam MA, Sahragardan N, Esfahlan RJ

Open source

DOI
10.1186/s12935-025-03977-7
Published
2025 Oct 3
Container
Cancer cell international
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12935-025-03977-7,
  title = {Niosome-loaded silibinin and methotrexate for synergistic breast cancer combination chemotherapy: in silico and in vitro study.},
  author = {Salemi A and Zenjanab MK and Adili Aghdam MA and Sahragardan N and Esfahlan RJ},
  year = {2025},
  journal = {Cancer cell international},
  doi = {10.1186/s12935-025-03977-7},
  url = {https://doi.org/10.1186/s12935-025-03977-7}
}

RIS

TY  - JOUR
TI  - Niosome-loaded silibinin and methotrexate for synergistic breast cancer combination chemotherapy: in silico and in vitro study.
AU  - Salemi A
AU  - Zenjanab MK
AU  - Adili Aghdam MA
AU  - Sahragardan N
AU  - Esfahlan RJ
PY  - 2025
JO  - Cancer cell international
DO  - 10.1186/s12935-025-03977-7
UR  - https://doi.org/10.1186/s12935-025-03977-7
ER  - 

APA

A, S., MK, Z., MA, A. A., N, S., & RJ, E. (2025). Niosome-loaded silibinin and methotrexate for synergistic breast cancer combination chemotherapy: in silico and in vitro study.. Cancer cell international. https://doi.org/10.1186/s12935-025-03977-7

Source records